Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21788 | 25045230 | J Korean Med Sci | Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension. | 2014 | Details |
| A21791 | 25043514 | Hepatology | Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. | 2014 | Details |
| A21797 | 25039333 | J Gastroenterol Hepatol | Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A21801 | 25035342 | Arterioscler Thromb Vasc Biol | Links between ectopic fat and vascular disease in humans. | 2014 | Details |
| A21816 | 25024624 | World J Gastroenterol | Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation. | 2014 | Details |
| A21818 | 25024598 | World J Gastroenterol | Nonalcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
| A21819 | 25024597 | World J Gastroenterol | Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. | 2014 | Details |
| A21823 | 25024593 | World J Gastroenterol | Modern approach to the clinical management of non-alcoholic fatty liver disease. | 2014 | Details |
| A21830 | 25018867 | Frontline Gastroenterol | Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. | 2013 | Details |
| A21837 | 25013373 | Int J Med Sci | Alanine aminotransferase-old biomarker and new concept: a review. | 2014 | Details |
| A21842 | 25008241 | Mol Cell Endocrinol | Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis. | 2014 | Details |
| A21862 | 24993140 | Blood Purif | Non-alcoholic fatty liver disease proven by transient elastography in hemodialysis patients: is it a new risk factor for adverse cardiovascular events? | 2014 | Details |
| A21888 | 24976709 | World J Gastroenterol | Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. | 2014 | Details |
| A21892 | 24976364 | Hepatol Res | Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non-alcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
| A21900 | 30310479 | Eur Cardiol | The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease. | 2014 | Details |
| A21903 | 24973316 | Gut | Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. | 2014 | Details |
| A21932 | 24956534 | Atherosclerosis | Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study. | 2014 | Details |
| A21935 | 24953607 | Life Sci | Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice. | 2014 | Details |
| A21938 | 24952382 | Lipids Health Dis | Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile. | 2014 | Details |
| A21944 | 24947770 | Eur J Intern Med | Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. | 2014 | Details |
| A21968 | 24926685 | PLoS One | Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. | 2014 | Details |
| A21973 | 24923289 | Horm Res Paediatr | Predictors of metabolic risk in childhood obesity. | 2014 | Details |
| A21975 | 24919841 | BMC Complement Altern Med | Effects of red pitaya juice supplementation on cardiovascular and hepatic changes in high-carbohydrate, high-fat diet-induced metabolic syndrome rats. | 2014 | Details |
| A21988 | 24910023 | J Gastroenterol Hepatol | Clinical association between non-alcoholic fatty liver disease and the development of hypertension. | 2014 | Details |
| A22010 | 24893617 | J Diabetes | Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：. | 2014 | Details |
| A22026 | 24868321 | World J Hepatol | Gender and racial differences in nonalcoholic fatty liver disease. | 2014 | Details |
| A22068 | 24843689 | J Diabetes Investig | Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. | 2013 | Details |
| A22076 | 24836834 | Transplant Proc | Nonalcoholic Fatty liver disease in renal transplant recipients proven by transient elastography. | 2014 | Details |
| A22081 | 24830635 | Horm Metab Res | Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling. | 2014 | Details |
| A22096 | 24824123 | Zhonghua Gan Zang Bing Za Zhi | [Relationship of non-alcoholic steatohepatitis with arterial endothelial function and atherosclerosis]. | 2014 | Details |
| A22132 | 24796231 | Hepatol Res | Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J). | 2014 | Details |
| A22140 | 24793441 | J Clin Lipidol | An assessment by the Statin Liver Safety Task Force: 2014 update. | 2014 | Details |
| A22142 | 24793347 | J Clin Lipidol | Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy. | 2014 | Details |
| A22155 | 24783906 | Med Arch | Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. | 2014 | Details |
| A22162 | 24777953 | Hepatology | Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22178 | 24765691 | J Indian Med Assoc | Insulin resistance and hypothyroidism: a complex relationship in non-alcoholic fatty liver disease. | 2013 | Details |
| A22197 | 24753460 | Nephrol Dial Transplant | Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. | 2014 | Details |
| A22209 | 24748332 | J Gastroenterol | Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study. | 2014 | Details |
| A22214 | 24745923 | Curr Pharm Des | Psoriasis and Vascular Risk : An Update. | 2014 | Details |
| A22219 | 24743428 | Arterioscler Thromb Vasc Biol | Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. | 2014 | Details |
| A22231 | 24737902 | Postgrad Med J | Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. | 2014 | Details |
| A22232 | 24736032 | Clin Res Hepatol Gastroenterol | Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population. | 2014 | Details |
| A22235 | 24733068 | Int J Mol Sci | Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. | 2014 | Details |
| A22238 | 24731669 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. | 2014 | Details |
| A22241 | 24729784 | Gastroenterol Res Pract | Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link? | 2014 | Details |
| A22245 | 24721975 | Heart | Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. | 2014 | Details |
| A22256 | 24716162 | J Tradit Complement Med | Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. | 2013 | Details |
| A22261 | 24709349 | Eur J Intern Med | Cholesterol control according to the presence of metabolic syndrome in coronary and diabetic patients. Relationship with non-alcoholic fatty liver disease. | 2014 | Details |
| A22267 | 24704629 | Atherosclerosis | Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease. | 2014 | Details |
| A22307 | 24677249 | Hepatology | Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. | 2014 | Details |
| A22310 | 24673432 | Expert Opin Pharmacother | Treatment options for managing atherogenic dyslipidemia and fatty liver disease. | 2014 | Details |
| A22320 | 24667349 | Eur J Gastroenterol Hepatol | Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22321 | 24665862 | Expert Rev Gastroenterol Hepatol | Management of fatty liver disease with the metabolic syndrome. | 2014 | Details |
| A22324 | 24660702 | AJR Am J Roentgenol | Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. | 2014 | Details |
| A22325 | 24660548 | Clin Lab | High-density lipoprotein size distribution can differ between subjects with alcoholic and non-alcoholic fatty liver disease. | 2014 | Details |
| A22328 | 24657400 | J Hepatol | Procoagulant imbalance in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22329 | 24656140 | Nutr Metab Cardiovasc Dis | Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. | 2014 | Details |
| A22330 | 24656139 | Nutr Metab Cardiovasc Dis | Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. | 2014 | Details |
| A22335 | 24652102 | J Gastroenterol | The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. | 2014 | Details |
| A22341 | 24650811 | BMJ Open | Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. | 2014 | Details |
| A22350 | 24646400 | Scand J Gastroenterol | Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first? | 2014 | Details |
| A22361 | 24637730 | J Clin Gastroenterol | Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease. | 2015 | Details |
| A22381 | 24629059 | Obes Rev | Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis. | 2014 | Details |
| A22391 | 24625239 | Diabetes Technol Ther | Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease. | 2014 | Details |
| A22394 | 24622718 | Lancet Diabetes Endocrinol | Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health. | 2014 | Details |
| A22419 | 24594085 | Nutr Metab Cardiovasc Dis | Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. | 2014 | Details |
| A22422 | 24588719 | J Med Food | A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis. | 2014 | Details |
| A22428 | 24587651 | World J Gastroenterol | Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. | 2014 | Details |
| A22429 | 24587650 | World J Gastroenterol | Clinical approaches to non-alcoholic fatty liver disease. | 2014 | Details |
| A22445 | 24572250 | J Am Heart Assoc | Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. | 2014 | Details |
| A22455 | 24556343 | Contemp Clin Trials | Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected]. | 2014 | Details |
| A22469 | 24535638 | Angiology | Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease. | 2014 | Details |
| A22508 | 24505484 | PLoS One | Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. | 2014 | Details |
| A22510 | 24503573 | Nephron Clin Pract | Association of fatty liver disease with nonfatal cardiovascular events in patients undergoing maintenance hemodialysis. | 2014 | Details |
| A22511 | 24500438 | Curr Opin Clin Nutr Metab Care | Fatty acid binding proteins: tissue-specific functions in health and disease. | 2014 | Details |
| A22518 | 24496399 | Food Funct | The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease. | 2014 | Details |
| A22519 | 24495527 | Proc Nutr Soc | 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk. | 2014 | Details |
| A22530 | 24489722 | PLoS One | Cigarette smoke toxins deposited on surfaces: implications for human health. | 2014 | Details |
| A22533 | 24486698 | Mol Cell Endocrinol | Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. | 2014 | Details |
| A22539 | 24480733 | Arch Med Res | Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease. | 2014 | Details |
| A22543 | 24475948 | Cardiovasc Diabetol | Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea? | 2014 | Details |
| A22550 | 24471572 | J Clin Endocrinol Metab | Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. | 2014 | Details |
| A22581 | 24445216 | J Hepatol | Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. | 2014 | Details |
| A22594 | 24434909 | Gerontology | Age-related consequences of childhood obesity. | 2014 | Details |
| A22598 | 24428677 | Expert Opin Pharmacother | New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. | 2014 | Details |
| A22610 | 24417071 | Klin Med (Mosk) | [Obesity and diseases of digestive organs]. | 2013 | Details |
| A22626 | 24401223 | Atherosclerosis | Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. | 2013 | Details |
| A22652 | 24381427 | Indian J Clin Biochem | A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease. | 2012 | Details |
| A22654 | 24379092 | Orv Hetil | [The role of fetuin-A in cardiovascular diseases]. | 2014 | Details |
| A22656 | 24378747 | Curr Opin Lipidol | Cholesterol precursors: more than mere markers of biosynthesis. | 2014 | Details |
| A22659 | 24378270 | Ann Hepatol | Statin use is not associated with liver related mortality. | 2014 | Details |
| A22663 | 24377153 | Trop Gastroenterol | Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. | 2014 | Details |
| A22666 | 24375485 | Hepatology | Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2013 | Details |
| A22678 | 26528002 | Clujul Med | From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? | 2014 | Details |
| A22683 | 26058106 | Eksp Klin Gastroenterol | [New metabolic index in the diagnosis of insulin resistance in patients with nonalcoholic fatty liver disease]. | 2014 | Details |
| A22685 | 25960770 | Diabetol Metab Syndr | A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease. | 2014 | Details |
| A22693 | 25842663 | Eksp Klin Gastroenterol | [Prevalence of nonalcoholic fatty liver disease in young patients with abdominal obesity and hypertension]. | 2014 | Details |
| A22697 | 25796866 | Wiad Lek | [Variants of the course of non-alcoholic fatty liver disease in patients with ischemic heart disease and possibility of hypolipidemic therapy]. | 2014 | Details |
| A22698 | 25796862 | Wiad Lek | [The assessment of cardiovascular risk factors in patients with nonalcoholic fatty liver disease]. | 2014 | Details |
| A22700 | 25796814 | Wiad Lek | Combined effect of appointment telmisartan and atorvastatin on hemodynamic indicators and the indicators of lipid profile in patients with arterial hypertension combined with obesity and steatohepatitis. | 2014 | Details |